Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 28 peer-reviewed journal articles Updated
Neurology

Building Your Care Team and Long-Term Management Strategy

At a Glance

Long-term management of migraine without aura works best as a personalized plan rather than a single pill. Consistent sleep, meals, hydration, gradual exercise, tracking, mental health support, neuromodulation, and coordinated medical care can reduce disability and improve daily life.

Living with migraine without aura requires a shift in perspective: from treating individual “events” to managing a lifelong neurological condition. Long-term success is rarely found in a single pill. Instead, it comes from a multimodal approach that combines consistent lifestyle habits, behavioral support, and a collaborative medical team [1][2][3].

Building a Consistent Foundation: SEEDS

Because the migraine brain is sensitive to change, specialists often recommend an adapted SEEDS approach to help stabilize the nervous system [1][4]. These habits are helpful adjuncts, not a cure; do not feel blamed if attacks continue despite good habits.

  • S (Sleep): Maintaining a consistent sleep schedule—going to bed and waking up at the same time every day—is a helpful way to lower your migraine frequency [5][4].
  • E (Exercise): Regular aerobic exercise (like brisk walking or swimming) can be beneficial [6]. However, because intense exertion can trigger an attack for some, it is best to start slowly and increase intensity gradually [7].
  • E (Eat/Hydration): Migraine is highly sensitive to metabolic shifts. Eating regular meals and staying consistently hydrated helps prevent energy crashes [2][8].
  • D (Diary): Keeping a simple diary helps identify patterns. A simple paper calendar or phone note is often adequate if it is not burdensome.
  • S (Stress Management): While you cannot eliminate stress, you can change how your nervous system reacts to it. Cognitive Behavioral Therapy (CBT) and mindfulness-based therapies have been shown to reduce migraine-related disability and improve quality of life [9][10].

Non-Drug Options: Neuromodulation

For those who prefer to avoid medications or who experience significant side effects, neuromodulation devices offer a high-tech alternative. These devices use electrical or magnetic pulses to calm the nerves involved in migraine [11].

  • Acute and Preventive: Some devices, like those that stimulate the trigeminal or vagus nerves, may be FDA-authorized for stopping an attack or preventing future ones, though authorization varies by device [12][13].
  • Safety: These are generally well-tolerated, with side effects typically limited to temporary skin irritation or a tingling sensation. However, you must have a clinician review for implanted electrical devices, relevant neurologic or cardiac conditions, skin problems, and other device-specific restrictions [14][15].

The Power of Data: Tracking What Matters

To help your doctor help you, you must move beyond a simple “headache count.” A high-quality migraine diary should track [16][17]:

  1. Migraine Days vs. Headache Days: A migraine day is based on migraine features and/or a day treated successfully as migraine; a headache day is any nonmigraine pain [18].
  2. Acute Medication Use: Record how many days you take pills to monitor for the risk of Medication Overuse Headache [19].
  3. Functional Impact: Use a scale like the MIDAS (a questionnaire measuring days of missed work/activities) or HIT-6 (a 6-question survey measuring how severely headaches impact your life) to track how many days you missed work, school, or family activities. Function is often a more important metric than pain intensity [20][21].
  4. The Interictal Burden: Note how you feel between attacks. Do you experience “fear of the next one” or lingering fatigue? This is a key part of your disease burden [17].

Addressing the Mental Health Connection

Migraine and mental health have a “bidirectional” relationship: chronic pain can lead to anxiety and depression, and these conditions can, in turn, make your migraine attacks more frequent and harder to treat [22][23].

  • Prevalence: People with chronic migraine are significantly more likely to experience depression or anxiety than those with fewer attacks [24].
  • Comprehensive Care: It is vital that your care team addresses your emotional well-being as a central part of your treatment, not as an afterthought [3][25].

Building Your Care Team

If your attacks are not well-controlled by a primary care doctor, you may need to see a neurologist or a headache specialist (a doctor with additional board certification in headache medicine) [26]. A qualified specialist should:

  • Perform a thorough neurological exam to rule out secondary causes [27].
  • Use validated tools to measure your disability [20].
  • Discuss the full range of modern treatments, including CGRP-targeted therapies and behavioral options [26][28].
  • Coordinate with other professionals, such as physical therapists or psychologists, to provide a truly multidisciplinary approach to your care [25].

When to Follow Up: Remember that migraine is a recurrent condition with a variable course. Follow up with your doctor if attacks change, if preventives stop working, or if your disability increases.

Common questions in this guide

What does long-term management of migraine without aura involve?
Long-term care usually combines consistent sleep, regular meals and hydration, gradual exercise, stress-management support, and a plan for acute or preventive treatment. A migraine diary and regular follow-up help your clinician adjust the plan. These habits can support control but are not a cure, and ongoing attacks are not a sign that you have failed.
What should I include in a migraine diary?
Record migraine days separately from other headache days, the days you use acute medication, and how attacks affect work, school, family activities, or daily tasks. You can also note sleep, mood, energy, and how you feel between attacks. Tools such as MIDAS and HIT-6 can help measure disability over time.
When should I see a neurologist or headache specialist for migraine?
Consider a specialist if your attacks are not well controlled by primary care, change in pattern, stop responding to preventive treatment, or cause increasing disability. A neurologist or headache specialist can perform a neurological examination, assess possible secondary causes, measure disability, and review medication, behavioral, and device options.
Can neuromodulation devices help with migraine without aura?
Some neuromodulation devices may be authorized for stopping an attack, preventing future attacks, or both, depending on the device. They are often well tolerated, but a clinician should review your medical history, implanted electrical devices, neurologic or cardiac conditions, skin issues, and other device-specific restrictions before use.
How can mental health support affect migraine care?
Migraine and anxiety or depression can worsen one another: ongoing pain may increase emotional distress, and these conditions can make attacks more frequent or harder to treat. Cognitive behavioral therapy, mindfulness-based therapy, and coordinated care with a mental health professional may reduce migraine-related disability and improve quality of life.
How should I measure whether my migraine treatment is working?
Success is not only fewer or less intense attacks; it also includes fewer days using acute medication, less missed work or family time, and less fear or fatigue between attacks. Your clinician may use measures such as MIDAS or HIT-6 along with your diary to track these changes and decide whether the plan needs adjustment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you routinely use disability scales like the MIDAS or HIT-6 to monitor how my treatment is working, or should I be providing those myself?
  2. 2.Are you comfortable prescribing and managing newer neuromodulation devices if I prefer a non-drug option for acute or preventive care?
  3. 3.Given the emotional toll of my attacks, do you have a behavioral psychologist or counselor you regularly collaborate with who understands migraine?
  4. 4.Are there specific red flags in my diary—such as my response to acute medication or my sleep patterns—that would suggest I need a different specialist, such as a sleep doctor?
  5. 5.How do you define 'success' for my long-term management: is it a 50% reduction in attack frequency, or are we aiming for a specific improvement in my daily functioning?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (28)
  1. 1

    Behavioral Management of Episodic Migraine: Maintaining a Healthy Consistent Lifestyle.

    Seng EK, Gosnell I, Sutton L, Grinberg AS

    Current pain and headache reports 2022; (26(3)):247-252 doi:10.1007/s11916-022-01023-z.

    PMID: 35212864
  2. 2

    The role of avoiding known triggers, embracing protectors, and adhering to healthy lifestyle recommendations in migraine prophylaxis: Insights from a prospective cohort of 1125 people with episodic migraine.

    Casanova A, Vives-Mestres M, Donoghue S, et al.

    Headache 2023; (63(1)):51-61 doi:10.1111/head.14451.

    PMID: 36651502
  3. 3

    Headache psychiatry: A structured narrative review and integrative framework.

    Otani K

    PCN reports : psychiatry and clinical neurosciences 2026; (5(2)):e70347 doi:10.1002/pcn5.70347.

    PMID: 42306499
  4. 4

    Sleep and Migraine: Assessment and Treatment of Comorbid Sleep Disorders.

    Rains JC

    Headache 2018; (58(7)):1074-1091 doi:10.1111/head.13357.

    PMID: 30095163
  5. 5

    Sleep disturbances in tension-type headache and migraine.

    Fernández-de-Las-Peñas C, Fernández-Muñoz JJ, Palacios-Ceña M, et al.

    Therapeutic advances in neurological disorders 2018; (11()):1756285617745444 doi:10.1177/1756285617745444.

    PMID: 29399051
  6. 6

    [Non-medical Approaches to Headache Prevention: What is the Evidence?]

    Schäfer B

    Fortschritte der Neurologie-Psychiatrie 2024; (92(7-08)):294-297 doi:10.1055/a-2318-8941.

    PMID: 38885654
  7. 7

    Aerobic Exercise for Reducing Migraine Burden: Mechanisms, Markers, and Models of Change Processes.

    Irby MB, Bond DS, Lipton RB, et al.

    Headache 2016; (56(2)):357-69 doi:10.1111/head.12738.

    PMID: 26643584
  8. 8

    Impact of fasting during Ramadan on migraine in the Algerian population.

    Goufa E, Chentouf A, Belabbas S, Boughrara W

    Neurologia 2025; (40(8)):762-767 doi:10.1016/j.nrleng.2025.09.010.

    PMID: 41076283
  9. 9

    Behavioral interventions for migraine prevention: A systematic review and meta-analysis.

    Treadwell JR, Tsou AY, Rouse B, et al.

    Headache 2025; (65(4)):668-694 doi:10.1111/head.14914.

    PMID: 39968795
  10. 10

    One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial.

    Dindo LN, Recober A, Calarge CA, et al.

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2020; (17(2)):743-753 doi:10.1007/s13311-019-00818-0.

    PMID: 31863406
  11. 11

    International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine.

    Yuan H, Orr SL, Al-Karagholi MAM, et al.

    Cephalalgia : an international journal of headache 2025; (45(10)):3331024251388377 doi:10.1177/03331024251388377.

    PMID: 41117312
  12. 12

    Neuromodulation in migraine.

    Arca KN, Lambru G, Starling AJ

    Handbook of clinical neurology 2024; (199()):179-200 doi:10.1016/B978-0-12-823357-3.00003-3.

    PMID: 38307646
  13. 13

    Neuromodulation for Headache Management in Pregnancy.

    Smirnoff L, Bravo M, Hyppolite T

    Current pain and headache reports 2025; (29(1)):14 doi:10.1007/s11916-024-01344-1.

    PMID: 39777577
  14. 14

    Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.

    Yarnitsky D, Dodick DW, Grosberg BM, et al.

    Headache 2019; (59(8)):1240-1252 doi:10.1111/head.13551.

    PMID: 31074005
  15. 15

    Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.

    VanderPluym JH, Halker Singh RB, Urtecho M, et al.

    JAMA 2021; (325(23)):2357-2369 doi:10.1001/jama.2021.7939.

    PMID: 34128998
  16. 16

    Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial.

    De Icco R, Vaghi G, Allena M, et al.

    The journal of headache and pain 2022; (23(1)):123 doi:10.1186/s10194-022-01480-2.

    PMID: 36115947
  17. 17

    Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a post hoc analysis from a phase 3 migraine prevention study.

    Lampl C, Lipton RB, Lipsius S, et al.

    Frontiers in neurology 2026; (17()):1808619 doi:10.3389/fneur.2026.1808619.

    PMID: 42327799
  18. 18

    Grey zones in the diagnosis of adult migraine without aura based on the International Classification of Headache Disorders-III beta: exploring the covariates of possible migraine without aura.

    Ozge A, Aydinlar E, Tasdelen B

    Pain research & management 2015; (20(1)):e1-7.

    PMID: 25493966
  19. 19

    Secondary headache attributed to exposure to or overuse of a substance.

    Toom K, Braschinsky M, Obermann M, Katsarava Z

    Cephalalgia : an international journal of headache 2021; (41(4)):443-452 doi:10.1177/0333102420942238.

    PMID: 32819151
  20. 20

    Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs).

    Haywood KL, Mars TS, Potter R, et al.

    Cephalalgia : an international journal of headache 2018; (38(7)):1374-1386 doi:10.1177/0333102417731348.

    PMID: 28920448
  21. 21

    Reliability, validity, and responsiveness of the Arabic version of HIT-6 questionnaire in patients with migraine indicated for preventive therapy: A multi-center study.

    Hussein M, Hassan A, Nada MAF, et al.

    Headache 2024; (64(5)):500-508 doi:10.1111/head.14719.

    PMID: 38651363
  22. 22

    The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

    Lipton RB, Seng EK, Chu MK, et al.

    Headache 2020; (60(8)):1683-1696 doi:10.1111/head.13914.

    PMID: 33448374
  23. 23

    Psychiatric comorbidities of migraine.

    McCracken HT, Thaxter LY, Smitherman TA

    Handbook of clinical neurology 2024; (199()):505-516 doi:10.1016/B978-0-12-823357-3.00013-6.

    PMID: 38307666
  24. 24

    Headache, depression and anxiety: associations in the Eurolight project.

    Lampl C, Thomas H, Tassorelli C, et al.

    The journal of headache and pain 2016; (17()):59 doi:10.1186/s10194-016-0649-2.

    PMID: 27245683
  25. 25

    Characteristics and management of headache among psychiatric outpatients at a Japanese general hospital: A retrospective study with an exploratory CGRP case series.

    Otani K, Imbe N, Shindo R

    PCN reports : psychiatry and clinical neurosciences 2025; (4(4)):e70235 doi:10.1002/pcn5.70235.

    PMID: 41181353
  26. 26

    Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update.

    Charles AC, Digre KB, Goadsby PJ, et al.

    Headache 2024; (64(4)):333-341 doi:10.1111/head.14692.

    PMID: 38466028
  27. 27

    Predictive performance of the common red flags in emergency department headache patients: a HEAD and HEAD-Colombia study.

    Chu K, Kelly AM, Kuan WS, et al.

    Emergency medicine journal : EMJ 2024; (41(6)):368-375 doi:10.1136/emermed-2023-213461.

    PMID: 38658053
  28. 28

    The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.

    Ailani J, Burch RC, Robbins MS,

    Headache 2021; (61(7)):1021-1039 doi:10.1111/head.14153.

    PMID: 34160823

This page explains long-term migraine without aura management for educational purposes and does not replace medical advice. Discuss lifestyle changes, devices, medications, and specialist referrals with your healthcare team.

Get notified when new evidence is published on migraine without aura.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.